1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Mast Cell Leukemia Global Clinical Trials Review, H1, 2014

Mast Cell Leukemia Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Mast Cell Leukemia Global Clinical Trials Review, H1, 2014" provides data on the Mast Cell Leukemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mast Cell Leukemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Mast Cell Leukemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Mast Cell Leukemia Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Mast Cell Leukemia 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Mast Cell Leukemia to Oncology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Mast Cell Leukemia to Oncology Clinical Trials 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Mast Cell Leukemia 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Prominent Drugs 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Novartis AG 26
Clinical Trial Overview of Novartis AG 26
Clinical Trial Overview of Top Institutes / Government 27
National Cancer Institute 27
Clinical Trial Overview of National Cancer Institute 27
Fred Hutchinson Cancer Research Center 28
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 28
Wake Forest University 29
Clinical Trial Overview of Wake Forest University 29
Stanford University 30
Clinical Trial Overview of Stanford University 30
City of Hope National Medical Center 31
Clinical Trial Overview of City of Hope National Medical Center 31
Five Key Clinical Profiles 32
Appendix 124
Abbreviations 124
Definitions 124
Research Methodology 125
Secondary Research 125
About GlobalData 126
Contact Us 126
Disclaimer 126
Source 127

List of Tables
Mast Cell Leukemia Therapeutics, Global, Clinical Trials by Region, 2014* 6
Mast Cell Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Mast Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Mast Cell Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Mast Cell Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Mast Cell Leukemia Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Mast Cell Leukemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Proportion of Mast Cell Leukemia to Oncology Clinical Trials, G7 Countries (%), 2014* 13
Mast Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Mast Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Mast Cell Leukemia to Oncology Clinical Trials, E7 Countries (%), 2014* 16
Mast Cell Leukemia Therapeutics, Global, Clinical Trials by Phase, 2014* 17
Mast Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 18
Mast Cell Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Mast Cell Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Mast Cell Leukemia Therapeutics, Global, Suspended Clinical Trials, 2014* 21
Mast Cell Leukemia Therapeutics, Global, Terminated Clinical Trials, 2014* 21
Mast Cell Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Mast Cell Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 23
Mast Cell Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Mast Cell Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
Mast Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 26
Mast Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 27
Mast Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014* 28
Mast Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2014* 29
Mast Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 30
Mast Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2014* 31

List of Figures
Mast Cell Leukemia Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Mast Cell Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Mast Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Mast Cell Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Mast Cell Leukemia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Mast Cell Leukemia to Oncology Clinical Trials, G7 Countries (%), 2014* 13
Mast Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Mast Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Mast Cell Leukemia to Oncology Clinical Trials, E7 Countries (%), 2014* 16
Mast Cell Leukemia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 17
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 18
Mast Cell Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Mast Cell Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Mast Cell Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Mast Cell Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 23
Mast Cell Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
GlobalData Methodology 125

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Chronic Myelocytic Leukemia (CML) - Market Insights, Epidemiology and Market Forecast-2023

Chronic Myelocytic Leukemia (CML) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Chronic Myelocytic Leukemia (CML) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the ...

Acute Myeloid Leukemia (AML) - Market Insights, Epidemiology and Market  Forecast-2023

Acute Myeloid Leukemia (AML) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Acute Myeloid Leukemia (AML) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...

Chronic lymphocytic leukemia- Market Insights, Epidemiology and Market Forecast-2023

Chronic lymphocytic leukemia- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Chronic lymphocytic leukemia - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.